Stay updated with breaking news from Dedee Murrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic arthritis (PsA) by up to 4 years, potentially preventing irreversible joint damage and deteriorating function for sufferers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus
Share this article Share this article SAN DIEGO, Dec. 11, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from the Phase 2b ADVISE trial evaluating the safety and efficacy of etrasimod, a highly selective, once-daily, oral sphingosine 1-phosphate (S1P) receptor modulator, in participants with moderate-to-severe atopic dermatitis (AD), will be presented at the Revolutionizing Atopic Dermatitis (RAD) 2020 Virtual Conference. "I am pleased to present the topline results from the ADVISE Phase 2 trial which support the rationale for etrasimod as a potentia...